GTS5:Table of Contents: Difference between revisions

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
==Growth factor receptors and related signalling pathways ([[GTS5:Growth factor receptors and related signalling pathways|Overview Page Link]])==
==Growth factor receptors and related signalling pathways ([[:GTS5:Growth factor receptors and related signalling pathways|Overview Page Link]] {{#ifeq: {{#show:GTS5:Growth factor receptors and related signalling pathways|Overview Page Link|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}})==


  '''Growth factor receptors'''
  '''Growth factor receptors'''
   - [[GTS5:Hereditary papillary renal carcinoma (MET)]]
   - [[:GTS5:Hereditary papillary renal carcinoma (MET)]] {{#ifeq: {{#show:GTS5:Hereditary papillary renal carcinoma (MET)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}
   - [[GTS5:Multiple endocrine neoplasia type 2 (RET)]]
   - [[:GTS5:Multiple endocrine neoplasia type 2 (RET)]] {{#ifeq: {{#show:GTS5:Multiple endocrine neoplasia type 2 (RET)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}
   - [[GTS5:Juvenile polyposis syndrome (BMPR1A, SMAD4)]]
   - [[:GTS5:Juvenile polyposis syndrome (BMPR1A, SMAD4)]] {{#ifeq: {{#show:GTS5:Juvenile polyposis syndrome (BMPR1A, SMAD4)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}
   - [[GTS5:Hereditary neuroblastoma (ALK, PHOX2B)]]
   - [[:GTS5:Hereditary neuroblastoma (ALK, PHOX2B)]] {{#ifeq: {{#show:GTS5:Hereditary neuroblastoma (ALK, PHOX2B)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}
   - [[GTS5:Encephalocraniocutaneous lipomatosis (FGFR1)]]
   - [[:GTS5:Encephalocraniocutaneous lipomatosis (FGFR1)]] {{#ifeq: {{#show:GTS5:Encephalocraniocutaneous lipomatosis (FGFR1)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}


  '''G-coupled protein receptor pathway'''
  '''G-coupled protein receptor pathway'''
   - [[GTS5:Glucagon cell hyperplasia and neoplasia (GCGR)]]
   - [[:GTS5:Glucagon cell hyperplasia and neoplasia (GCGR)]] {{#ifeq: {{#show:GTS5:Glucagon cell hyperplasia and neoplasia (GCGR)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}
   - [[GTS5:McCune-Albright syndrome (GNAS)]]
   - [[:GTS5:McCune-Albright syndrome (GNAS)]] {{#ifeq: {{#show:GTS5:McCune-Albright syndrome (GNAS)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}
   - [[GTS5:Sturge-Weber syndrome (GNAQ)]]
   - [[:GTS5:Sturge-Weber syndrome (GNAQ)]] {{#ifeq: {{#show:GTS5:Sturge-Weber syndrome (GNAQ)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}


  '''RAS-MAPK pathway'''
  '''RAS-MAPK pathway'''
   - [[GTS5:Neurofibromatosis type 1 (NF1)]]
   - [[:GTS5:Neurofibromatosis type 1 (NF1)]] {{#ifeq: {{#show:GTS5:Neurofibromatosis type 1 (NF1)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}
   - [[GTS5:NF2-related schwannomatosis (NF2)]]
   - [[:GTS5:NF2-related schwannomatosis (NF2)]] {{#ifeq: {{#show:GTS5:NF2-related schwannomatosis (NF2)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}
   - [[GTS5:Costello syndrome (HRAS)]]
   - [[:GTS5:Costello syndrome (HRAS)]] {{#ifeq: {{#show:GTS5:Costello syndrome (HRAS)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}
   - [[GTS5:Noonan syndrome (Various genes)]]
   - [[:GTS5:Noonan syndrome (Various genes)]] {{#ifeq: {{#show:GTS5:Noonan syndrome (Various genes)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}
   - [[GTS5:Schimmelpenning-Feuerstein-Mims (HRAS, KRAS)]]
   - [[:GTS5:Schimmelpenning-Feuerstein-Mims (HRAS, KRAS)]] {{#ifeq: {{#show:GTS5:Schimmelpenning-Feuerstein-Mims (HRAS, KRAS)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}


  '''PKA signalling pathway'''
  '''PKA signalling pathway'''
   - [[GTS5:Carney complex (PRKAR1A, PDE8B, PDE11A)]]
   - [[:GTS5:Carney complex (PRKAR1A, PDE8B, PDE11A)]] {{#ifeq: {{#show:GTS5:Carney complex (PRKAR1A, PDE8B, PDE11A)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}
   - [[GTS5:PROS syndrome (PIK3CA)]]
   - [[:GTS5:PROS syndrome (PIK3CA)]] {{#ifeq: {{#show:GTS5:PROS syndrome (PIK3CA)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}


  '''WNT/TGFbeta pathway'''
  '''WNT/TGFbeta pathway'''
   - [[GTS5:Familial adenomatous polyposis (APC)]]
   - [[:GTS5:Familial adenomatous polyposis (APC)]] {{#ifeq: {{#show:GTS5:Familial adenomatous polyposis (APC)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}
   - [[GTS5:Gastric Adenocarcinoma and Proximal Polyposis of Stomach - GAPPS (APC promoter)]]
   - [[:GTS5:Gastric Adenocarcinoma and Proximal Polyposis of Stomach - GAPPS (APC promoter)]] {{#ifeq: {{#show:GTS5:Gastric Adenocarcinoma and Proximal Polyposis of Stomach - GAPPS (APC promoter)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}
   - [[GTS5:AXIN2-associated polyposis (AXIN2)]]
   - [[:GTS5:AXIN2-associated polyposis (AXIN2)]] {{#ifeq: {{#show:GTS5:AXIN2-associated polyposis (AXIN2)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}
   - [[GTS5:Serrated polyposis (RNF43)]]
   - [[:GTS5:Serrated polyposis (RNF43)]] {{#ifeq: {{#show:GTS5:Serrated polyposis (RNF43)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}
   - [[GTS5:WT1 related tumour predisposition syndrome (WT1)]]
   - [[:GTS5:WT1 related tumour predisposition syndrome (WT1)]] {{#ifeq: {{#show:GTS5:WT1 related tumour predisposition syndrome (WT1)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}
   - [[GTS5:WAGR syndrome (WT1)]]
   - [[:GTS5:WAGR syndrome (WT1)]] {{#ifeq: {{#show:GTS5:WAGR syndrome (WT1)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}
   - [[GTS5:Multiple endocrine neoplasia type 1 (MEN1)]]
   - [[:GTS5:Multiple endocrine neoplasia type 1 (MEN1)]] {{#ifeq: {{#show:GTS5:Multiple endocrine neoplasia type 1 (MEN1)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}
   - [[GTS5:Peutz-Jeghers syndrome (STK11)]]
   - [[:GTS5:Peutz-Jeghers syndrome (STK11)]] {{#ifeq: {{#show:GTS5:Peutz-Jeghers syndrome (STK11)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}
   - [[GTS5:Hereditary gastric and breast cancer syndrome (CDH1, CTNNA1)]]
   - [[:GTS5:Hereditary gastric and breast cancer syndrome (CDH1, CTNNA1)]] {{#ifeq: {{#show:GTS5:Hereditary gastric and breast cancer syndrome (CDH1, CTNNA1)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}
   - [[GTS5:Hereditary mixed polyposis syndrome (GREM1)]]
   - [[:GTS5:Hereditary mixed polyposis syndrome (GREM1)]] {{#ifeq: {{#show:GTS5:Hereditary mixed polyposis syndrome (GREM1)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}


  '''Hedgehog signalling pathway'''
  '''Hedgehog signalling pathway'''
   - [[GTS5:Naevoid basal cell carcinoma syndrome - Gorlin syndrome (PTCH1, SUFU, GPR161)]]
   - [[:GTS5:Naevoid basal cell carcinoma syndrome - Gorlin syndrome (PTCH1, SUFU, GPR161)]] {{#ifeq: {{#show:GTS5:Naevoid basal cell carcinoma syndrome - Gorlin syndrome (PTCH1, SUFU, GPR161)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}
   - [[GTS5:SMO-related Curry-Jones syndrome (SMO)]]
   - [[:GTS5:SMO-related Curry-Jones syndrome (SMO)]] {{#ifeq: {{#show:GTS5:SMO-related Curry-Jones syndrome (SMO)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}
   - [[GTS5:ELP1-related medulloblastoma predisposition syndrome(ELP1)]]
   - [[:GTS5:ELP1-related medulloblastoma predisposition syndrome(ELP1)]] {{#ifeq: {{#show:GTS5:ELP1-related medulloblastoma predisposition syndrome(ELP1)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}
   - [[GTS5:Osteochondromatosis (EXT1, EXT2)]]
   - [[:GTS5:Osteochondromatosis (EXT1, EXT2)]] {{#ifeq: {{#show:GTS5:Osteochondromatosis (EXT1, EXT2)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}


  '''NF-kB signalling pathway'''
  '''NF-kB signalling pathway'''
   - [[GTS5:Brooke-Spiegler syndrome (CYLD)]]
   - [[:GTS5:Brooke-Spiegler syndrome (CYLD)]] {{#ifeq: {{#show:GTS5:Brooke-Spiegler syndrome (CYLD)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}


  '''MTOR and PI3K pathway'''
  '''MTOR and PI3K pathway'''
   - [[GTS5:Tuberous sclerosis (TSC1, TSC1)]]
   - [[:GTS5:Tuberous sclerosis (TSC1, TSC1)]] {{#ifeq: {{#show:GTS5:Tuberous sclerosis (TSC1, TSC1)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}
   - [[GTS5:PTEN hamartoma tumour syndrome (PTEN)]]
   - [[:GTS5:PTEN hamartoma tumour syndrome (PTEN)]] {{#ifeq: {{#show:GTS5:PTEN hamartoma tumour syndrome (PTEN)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}
   - [[GTS5:Activated Phosphatidylinositol-3-OH kinase δ Syndrome - APDS (PIK3CD)]]
   - [[:GTS5:Activated Phosphatidylinositol-3-OH kinase δ Syndrome - APDS (PIK3CD)]] {{#ifeq: {{#show:GTS5:Activated Phosphatidylinositol-3-OH kinase δ Syndrome - APDS (PIK3CD)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}


  '''Transcription factors and regulators'''
  '''Transcription factors and regulators'''
   - [[GTS5:Multiple endocrine neoplasia type 5, MAX related tumours (MAX)]]
   - [[:GTS5:Multiple endocrine neoplasia type 5, MAX related tumours (MAX)]] {{#ifeq: {{#show:GTS5:Multiple endocrine neoplasia type 5, MAX related tumours (MAX)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}
   - [[GTS5:MAFA-related familial insulinomatosis (MAFA)]]
   - [[:GTS5:MAFA-related familial insulinomatosis (MAFA)]] {{#ifeq: {{#show:GTS5:MAFA-related familial insulinomatosis (MAFA)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}
   - [[GTS5:Birt-Hogg-Dube syndrome (FLCN)]]
   - [[:GTS5:Birt-Hogg-Dube syndrome (FLCN)]] {{#ifeq: {{#show:GTS5:Birt-Hogg-Dube syndrome (FLCN)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}
   - [[GTS5:Familial chordoma (TBXT)]]
   - [[:GTS5:Familial chordoma (TBXT)]] {{#ifeq: {{#show:GTS5:Familial chordoma (TBXT)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}
   - [[GTS5:Hyperparathyroidism jaw tumour syndrome (CDC73)]]
   - [[:GTS5:Hyperparathyroidism jaw tumour syndrome (CDC73)]] {{#ifeq: {{#show:GTS5:Hyperparathyroidism jaw tumour syndrome (CDC73)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}


==Oxidative stress response and metabolism ([[GTS5:Oxidative stress response and metabolism|Overview Page Link]])==
==Oxidative stress response and metabolism ([[:GTS5:Oxidative stress response and metabolism|Overview Page Link]] {{#ifeq: {{#show:GTS5:Oxidative stress response and metabolism|Overview Page Link|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}})==


  '''Angiogenesis'''
  '''Angiogenesis'''
   - [[GTS5:Von Hippel-Lindau syndrome (VHL)]]
   - [[:GTS5:Von Hippel-Lindau syndrome (VHL)]] {{#ifeq: {{#show:GTS5:Von Hippel-Lindau syndrome (VHL)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}


  '''Krebs cycle'''
  '''Krebs cycle'''
   - [[GTS5:SDH-deficient tumour syndrome - Hereditary phaeochromocytoma-paraganglioma syndromes (SDHA, SDHB, SDHC, SDHD, SDHAF2)]]
   - [[:GTS5:SDH-deficient tumour syndrome - Hereditary phaeochromocytoma-paraganglioma syndromes (SDHA, SDHB, SDHC, SDHD, SDHAF2)]] {{#ifeq: {{#show:GTS5:SDH-deficient tumour syndrome - Hereditary phaeochromocytoma-paraganglioma syndromes (SDHA, SDHB, SDHC, SDHD, SDHAF2)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}
   - [[GTS5:Hereditary leiomyomatosis and renal cell carcinoma syndrome (FH)]]
   - [[:GTS5:Hereditary leiomyomatosis and renal cell carcinoma syndrome (FH)]] {{#ifeq: {{#show:GTS5:Hereditary leiomyomatosis and renal cell carcinoma syndrome (FH)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}


  '''Toxic metabolite-mediated disorders'''
  '''Toxic metabolite-mediated disorders'''
   - [[GTS5:Hereditary tyrosinaemia type 1 (FAH)]]
   - [[:GTS5:Hereditary tyrosinaemia type 1 (FAH)]] {{#ifeq: {{#show:GTS5:Hereditary tyrosinaemia type 1 (FAH)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}


==Cell cycle and apoptosis pathways ([[GTS5:Cell cycle and apoptosis pathways|Overview Page Link]])==
==Cell cycle and apoptosis pathways ([[:GTS5:Cell cycle and apoptosis pathways|Overview Page Link]] {{#ifeq: {{#show:GTS5:Cell cycle and apoptosis pathways|Overview Page Link|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}})==


  '''P53 pathway'''
  '''P53 pathway'''
   - [[GTS5:Li-Fraumeni syndrome (TP53)]]
   - [[:GTS5:Li-Fraumeni syndrome (TP53)]] {{#ifeq: {{#show:GTS5:Li-Fraumeni syndrome (TP53)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}


  '''RB pathway'''
  '''RB pathway'''
   - [[GTS5:Retinoblastoma syndrome (RB1)]]
   - [[:GTS5:Retinoblastoma syndrome (RB1)]] {{#ifeq: {{#show:GTS5:Retinoblastoma syndrome (RB1)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}
   - [[GTS5:Multiple endocrine neoplasia type 4 (CDKN1B)]]
   - [[:GTS5:Multiple endocrine neoplasia type 4 (CDKN1B)]] {{#ifeq: {{#show:GTS5:Multiple endocrine neoplasia type 4 (CDKN1B)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}
   - [[GTS5:CDKN2A-related tumour predisposition syndrome (CDKN2A)]]
   - [[:GTS5:CDKN2A-related tumour predisposition syndrome (CDKN2A)]] {{#ifeq: {{#show:GTS5:CDKN2A-related tumour predisposition syndrome (CDKN2A)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}
   - [[GTS5:CDK4-related melanoma predisposition syndrome (CDK4)]]
   - [[:GTS5:CDK4-related melanoma predisposition syndrome (CDK4)]] {{#ifeq: {{#show:GTS5:CDK4-related melanoma predisposition syndrome (CDK4)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}


  '''FAS pathway'''
  '''FAS pathway'''
   - [[GTS5:Autoimmune lymphoproliferative syndrome (FAS)]]
   - [[:GTS5:Autoimmune lymphoproliferative syndrome (FAS)]] {{#ifeq: {{#show:GTS5:Autoimmune lymphoproliferative syndrome (FAS)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}


==DNA repair and genomic stability ([[GTS5:DNA repair and genomic stability|Overview Page Link]])==
==DNA repair and genomic stability ([[:GTS5:DNA repair and genomic stability|Overview Page Link]] {{#ifeq: {{#show:GTS5:DNA repair and genomic stability|Overview Page Link|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}})==


  '''Mismatch repair'''
  '''Mismatch repair'''
   - [[GTS5:Lynch Syndrome (MLH1, PMS2, MSH2, MSH6)]]
   - [[:GTS5:Lynch Syndrome (MLH1, PMS2, MSH2, MSH6)]] {{#ifeq: {{#show:GTS5:Lynch Syndrome (MLH1, PMS2, MSH2, MSH6)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}
   - [[GTS5:Muir-Torre syndrome (MLH1, PMS2, MSH2, MSH6)]]
   - [[:GTS5:Muir-Torre syndrome (MLH1, PMS2, MSH2, MSH6)]] {{#ifeq: {{#show:GTS5:Muir-Torre syndrome (MLH1, PMS2, MSH2, MSH6)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}
   - [[GTS5:Constitutional mismatch repair deficiency (CMMRD) syndrome (MLH1, PMS2, MSH2, MSH6)]]
   - [[:GTS5:Constitutional mismatch repair deficiency (CMMRD) syndrome (MLH1, PMS2, MSH2, MSH6)]] {{#ifeq: {{#show:GTS5:Constitutional mismatch repair deficiency (CMMRD) syndrome (MLH1, PMS2, MSH2, MSH6)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}


  '''Homologous recombination'''
  '''Homologous recombination'''
   - [[GTS5:BRCA-related cancer predisposition syndrome (BRCA1, BRCA2)]]
   - [[:GTS5:BRCA-related cancer predisposition syndrome (BRCA1, BRCA2)]] {{#ifeq: {{#show:GTS5:BRCA-related cancer predisposition syndrome (BRCA1, BRCA2)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}
   - [[GTS5:PALB2-related cancer predisposition syndrome (PALB2)]]
   - [[:GTS5:PALB2-related cancer predisposition syndrome (PALB2)]] {{#ifeq: {{#show:GTS5:PALB2-related cancer predisposition syndrome (PALB2)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}
   - [[GTS5:RAD51-related cancer predisposition syndrome (RAD51C, RAD51D)]]
   - [[:GTS5:RAD51-related cancer predisposition syndrome (RAD51C, RAD51D)]] {{#ifeq: {{#show:GTS5:RAD51-related cancer predisposition syndrome (RAD51C, RAD51D)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}
   - [[GTS5:Fanconi anaemia (FANC genes)]]
   - [[:GTS5:Fanconi anaemia (FANC genes)]] {{#ifeq: {{#show:GTS5:Fanconi anaemia (FANC genes)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}


  '''Base excision repair genes'''
  '''Base excision repair genes'''
   - [[GTS5:MUTYH-associated polyposis (MUTYH)]]
   - [[:GTS5:MUTYH-associated polyposis (MUTYH)]] {{#ifeq: {{#show:GTS5:MUTYH-associated polyposis (MUTYH)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}
   - [[GTS5:NTHL1-related tumour syndrome (NTHL1)]]
   - [[:GTS5:NTHL1-related tumour syndrome (NTHL1)]] {{#ifeq: {{#show:GTS5:NTHL1-related tumour syndrome (NTHL1)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}
   - [[GTS5:MBD4-associated neoplasia syndrome (MBD4)]]
   - [[:GTS5:MBD4-associated neoplasia syndrome (MBD4)]] {{#ifeq: {{#show:GTS5:MBD4-associated neoplasia syndrome (MBD4)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}


  '''Deficient nucleotide excision repair (NER) of DNA damage'''
  '''Deficient nucleotide excision repair (NER) of DNA damage'''
   - [[GTS5:Xeroderma Pigmentosum]]
   - [[:GTS5:Xeroderma Pigmentosum]] {{#ifeq: {{#show:GTS5:Xeroderma Pigmentosum|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}


  '''Non-homologous end joining (NHEJ)'''
  '''Non-homologous end joining (NHEJ)'''
   - [[GTS5:Ataxia-telangiectasia syndrome (ATM)]]
   - [[:GTS5:Ataxia-telangiectasia syndrome (ATM)]] {{#ifeq: {{#show:GTS5:Ataxia-telangiectasia syndrome (ATM)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}
   - [[GTS5:CHEK2-related hereditary (breast) cancer predisposition syndrome (CHEK2)]]
   - [[:GTS5:CHEK2-related hereditary (breast) cancer predisposition syndrome (CHEK2)]] {{#ifeq: {{#show:GTS5:CHEK2-related hereditary (breast) cancer predisposition syndrome (CHEK2)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}
   - [[GTS5:Nijmegen breakage syndrome (NBN)]]
   - [[:GTS5:Nijmegen breakage syndrome (NBN)]] {{#ifeq: {{#show:GTS5:Nijmegen breakage syndrome (NBN)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}


  '''DNA Polymerization'''
  '''DNA Polymerization'''
   - [[GTS5:Polymerase proofreading-associated polyposis (POLD1, POLE)]]
   - [[:GTS5:Polymerase proofreading-associated polyposis (POLD1, POLE)]] {{#ifeq: {{#show:GTS5:Polymerase proofreading-associated polyposis (POLD1, POLE)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}


  '''Helicases'''
  '''Helicases'''
   - [[GTS5:Bloom syndrome (BLM)]]
   - [[:GTS5:Bloom syndrome (BLM)]] {{#ifeq: {{#show:GTS5:Bloom syndrome (BLM)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}
   - [[GTS5:Werner syndrome (WRN)]]
   - [[:GTS5:Werner syndrome (WRN)]] {{#ifeq: {{#show:GTS5:Werner syndrome (WRN)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}
   - [[GTS5:Rothmund-Thomson syndrome (ANAPC1, RECQL4)]]
   - [[:GTS5:Rothmund-Thomson syndrome (ANAPC1, RECQL4)]] {{#ifeq: {{#show:GTS5:Rothmund-Thomson syndrome (ANAPC1, RECQL4)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}
   - [[GTS5:DDX41-related haematologic tumour predisposition syndrome (DDX41)]]
   - [[:GTS5:DDX41-related haematologic tumour predisposition syndrome (DDX41)]] {{#ifeq: {{#show:GTS5:DDX41-related haematologic tumour predisposition syndrome (DDX41)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}


  '''Chromosomal non-dysjunction (aneuploidy) syndromes'''
  '''Chromosomal non-dysjunction (aneuploidy) syndromes'''
   - [[GTS5:Mosaic variegated aneuploidy (BUB1B, CEP57, TRIP13, BUB1, BUB3)]]
   - [[:GTS5:Mosaic variegated aneuploidy (BUB1B, CEP57, TRIP13, BUB1, BUB3)]] {{#ifeq: {{#show:GTS5:Mosaic variegated aneuploidy (BUB1B, CEP57, TRIP13, BUB1, BUB3)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}
   - [[GTS5:Klinefelter syndrome]]
   - [[:GTS5:Klinefelter syndrome]] {{#ifeq: {{#show:GTS5:Klinefelter syndrome|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}
   - [[GTS5:Turner syndrome]]
   - [[:GTS5:Turner syndrome]] {{#ifeq: {{#show:GTS5:Turner syndrome|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}
   - [[GTS5:Down syndrome]]
   - [[:GTS5:Down syndrome]] {{#ifeq: {{#show:GTS5:Down syndrome|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}


==Telomere maintenance ([[GTS5:Telomere maintenance|Overview Page Link]])==
==Telomere maintenance ([[:GTS5:Telomere maintenance|Overview Page Link]] {{#ifeq: {{#show:GTS5:Telomere maintenance|Overview Page Link|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}})==
   
   
  '''Telomere biology disorders'''
  '''Telomere biology disorders'''
   - [[GTS5:Dyskeratosis congenita (DKC1, TERT, TERC, TINF2, Other IBMFS genes)]]
   - [[:GTS5:Dyskeratosis congenita (DKC1, TERT, TERC, TINF2, Other IBMFS genes)]] {{#ifeq: {{#show:GTS5:Dyskeratosis congenita (DKC1, TERT, TERC, TINF2, Other IBMFS genes)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}
   - [[GTS5:POT1 and Shelterin-related tumour predisposition syndrome (POT1, ACD, TERF2IP, TERT promoter)]]
   - [[:GTS5:POT1 and Shelterin-related tumour predisposition syndrome (POT1, ACD, TERF2IP, TERT promoter)]] {{#ifeq: {{#show:GTS5:POT1 and Shelterin-related tumour predisposition syndrome (POT1, ACD, TERF2IP, TERT promoter)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}


==Epigenetic drivers and chromatin remodelling ([[GTS5:pigenetic drivers and chromatin remodelling|Overview Page Link]])==
==Epigenetic drivers and chromatin remodelling ([[:GTS5:pigenetic drivers and chromatin remodelling|Overview Page Link]] {{#ifeq: {{#show:GTS5:pigenetic drivers and chromatin remodelling|Overview Page Link|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}})==


  '''Imprinting disorders'''
  '''Imprinting disorders'''
   - [[GTS5:Beckwith-Wiedemann spectrum (IGF2; CDKN1C)]]
   - [[:GTS5:Beckwith-Wiedemann spectrum (IGF2; CDKN1C)]] {{#ifeq: {{#show:GTS5:Beckwith-Wiedemann spectrum (IGF2; CDKN1C)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}


  '''Histone and DNA methylation'''
  '''Histone and DNA methylation'''
   - [[GTS5:Enchondromatosis (IDH1, IDH2)]]
   - [[:GTS5:Enchondromatosis (IDH1, IDH2)]] {{#ifeq: {{#show:GTS5:Enchondromatosis (IDH1, IDH2)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}


  '''Chromatin remodelling pathway'''
  '''Chromatin remodelling pathway'''
   - [[GTS5:Rhabdoid tumour predisposition syndrome (SMARCB1, SMARCA4)]]
   - [[:GTS5:Rhabdoid tumour predisposition syndrome (SMARCB1, SMARCA4)]] {{#ifeq: {{#show:GTS5:Rhabdoid tumour predisposition syndrome (SMARCB1, SMARCA4)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}
   - [[GTS5:Schwannomatosis (SMARCB1, LZTR1)]]
   - [[:GTS5:Schwannomatosis (SMARCB1, LZTR1)]] {{#ifeq: {{#show:GTS5:Schwannomatosis (SMARCB1, LZTR1)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}
   - [[GTS5:Clear cell meningioma predisposition syndrome (SMARCE1)]]
   - [[:GTS5:Clear cell meningioma predisposition syndrome (SMARCE1)]] {{#ifeq: {{#show:GTS5:Clear cell meningioma predisposition syndrome (SMARCE1)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}
   - [[GTS5:Weaver syndrome (EZH2)]]
   - [[:GTS5:Weaver syndrome (EZH2)]] {{#ifeq: {{#show:GTS5:Weaver syndrome (EZH2)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}


==RNA regulation ([[GTS5:RNA regulation|Overview Page Link]])==
==RNA regulation ([[:GTS5:RNA regulation|Overview Page Link]] {{#ifeq: {{#show:GTS5:RNA regulation|Overview Page Link|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}})==


  '''MicroRNA'''
  '''MicroRNA'''
   - [[GTS5:DICER1-related tumour predisposition syndrome (DICER1)]]
   - [[:GTS5:DICER1-related tumour predisposition syndrome (DICER1)]] {{#ifeq: {{#show:GTS5:DICER1-related tumour predisposition syndrome (DICER1)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}
   - [[GTS5:MicroRNA processor tumour predisposition syndromes (DROSHA, DGCR8)]]
   - [[:GTS5:MicroRNA processor tumour predisposition syndromes (DROSHA, DGCR8)]] {{#ifeq: {{#show:GTS5:MicroRNA processor tumour predisposition syndromes (DROSHA, DGCR8)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}


  '''RNA splicing'''
  '''RNA splicing'''
   - [[GTS5:Goldenhar syndrome (MYT1, SF3B2)]]
   - [[:GTS5:Goldenhar syndrome (MYT1, SF3B2)]] {{#ifeq: {{#show:GTS5:Goldenhar syndrome (MYT1, SF3B2)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}


==Protein regulation ([[GTS5:Protein regulation|Overview Page Link]])==
==Protein regulation ([[:GTS5:Protein regulation|Overview Page Link]] {{#ifeq: {{#show:GTS5:Protein regulation|Overview Page Link|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}})==


  '''Ubiquitin pathway'''
  '''Ubiquitin pathway'''
   - [[GTS5:BAP1-related tumour predisposition syndrome (BAP1)]]
   - [[:GTS5:BAP1-related tumour predisposition syndrome (BAP1)]] {{#ifeq: {{#show:GTS5:BAP1-related tumour predisposition syndrome (BAP1)|?Page Status|default=Complete}} | Complete | <span style="color:#0C7BDC"> Complete </span>| <span style="color:#FFC20A"> Incomplete </span>}}

Revision as of 12:03, 20 October 2026

Growth factor receptors and related signalling pathways (Overview Page Link Complete )

Growth factor receptors
  - GTS5:Hereditary papillary renal carcinoma (MET)  Incomplete 
  - GTS5:Multiple endocrine neoplasia type 2 (RET)  Incomplete 
  - GTS5:Juvenile polyposis syndrome (BMPR1A, SMAD4)  Incomplete 
  - GTS5:Hereditary neuroblastoma (ALK, PHOX2B)  Incomplete 
  - GTS5:Encephalocraniocutaneous lipomatosis (FGFR1)  Incomplete 
G-coupled protein receptor pathway
  - GTS5:Glucagon cell hyperplasia and neoplasia (GCGR)  Incomplete 
  - GTS5:McCune-Albright syndrome (GNAS)  Incomplete 
  - GTS5:Sturge-Weber syndrome (GNAQ)  Incomplete 
RAS-MAPK pathway
  - GTS5:Neurofibromatosis type 1 (NF1)  Incomplete 
  - GTS5:NF2-related schwannomatosis (NF2)  Incomplete 
  - GTS5:Costello syndrome (HRAS)  Incomplete 
  - GTS5:Noonan syndrome (Various genes)  Incomplete 
  - GTS5:Schimmelpenning-Feuerstein-Mims (HRAS, KRAS)  Incomplete 
PKA signalling pathway
  - GTS5:Carney complex (PRKAR1A, PDE8B, PDE11A)  Incomplete 
  - GTS5:PROS syndrome (PIK3CA)  Incomplete 
WNT/TGFbeta pathway
  - GTS5:Familial adenomatous polyposis (APC)  Incomplete 
  - GTS5:Gastric Adenocarcinoma and Proximal Polyposis of Stomach - GAPPS (APC promoter)  Incomplete 
  - GTS5:AXIN2-associated polyposis (AXIN2)  Incomplete 
  - GTS5:Serrated polyposis (RNF43)  Incomplete 
  - GTS5:WT1 related tumour predisposition syndrome (WT1)  Incomplete 
  - GTS5:WAGR syndrome (WT1)  Incomplete 
  - GTS5:Multiple endocrine neoplasia type 1 (MEN1)  Incomplete 
  - GTS5:Peutz-Jeghers syndrome (STK11)  Incomplete 
  - GTS5:Hereditary gastric and breast cancer syndrome (CDH1, CTNNA1)  Incomplete 
  - GTS5:Hereditary mixed polyposis syndrome (GREM1)  Incomplete 
Hedgehog signalling pathway
  - GTS5:Naevoid basal cell carcinoma syndrome - Gorlin syndrome (PTCH1, SUFU, GPR161)  Incomplete 
  - GTS5:SMO-related Curry-Jones syndrome (SMO)  Incomplete 
  - GTS5:ELP1-related medulloblastoma predisposition syndrome(ELP1)  Incomplete 
  - GTS5:Osteochondromatosis (EXT1, EXT2)  Incomplete 
NF-kB signalling pathway
  - GTS5:Brooke-Spiegler syndrome (CYLD)  Incomplete 
MTOR and PI3K pathway
  - GTS5:Tuberous sclerosis (TSC1, TSC1)  Incomplete 
  - GTS5:PTEN hamartoma tumour syndrome (PTEN)  Incomplete 
  - GTS5:Activated Phosphatidylinositol-3-OH kinase δ Syndrome - APDS (PIK3CD)  Incomplete 
Transcription factors and regulators
  - GTS5:Multiple endocrine neoplasia type 5, MAX related tumours (MAX)  Incomplete 
  - GTS5:MAFA-related familial insulinomatosis (MAFA)  Incomplete 
  - GTS5:Birt-Hogg-Dube syndrome (FLCN)  Incomplete 
  - GTS5:Familial chordoma (TBXT)  Incomplete 
  - GTS5:Hyperparathyroidism jaw tumour syndrome (CDC73)  Incomplete 

Oxidative stress response and metabolism (Overview Page Link Complete )

Angiogenesis
  - GTS5:Von Hippel-Lindau syndrome (VHL)  Incomplete 
Krebs cycle
  - GTS5:SDH-deficient tumour syndrome - Hereditary phaeochromocytoma-paraganglioma syndromes (SDHA, SDHB, SDHC, SDHD, SDHAF2)  Incomplete 
  - GTS5:Hereditary leiomyomatosis and renal cell carcinoma syndrome (FH)  Incomplete 
Toxic metabolite-mediated disorders
  - GTS5:Hereditary tyrosinaemia type 1 (FAH)  Incomplete 

Cell cycle and apoptosis pathways (Overview Page Link Complete )

P53 pathway
  - GTS5:Li-Fraumeni syndrome (TP53)  Incomplete 
RB pathway
  - GTS5:Retinoblastoma syndrome (RB1)  Incomplete 
  - GTS5:Multiple endocrine neoplasia type 4 (CDKN1B)  Incomplete 
  - GTS5:CDKN2A-related tumour predisposition syndrome (CDKN2A)  Incomplete 
  - GTS5:CDK4-related melanoma predisposition syndrome (CDK4)  Incomplete 
FAS pathway
  - GTS5:Autoimmune lymphoproliferative syndrome (FAS)  Incomplete 

DNA repair and genomic stability (Overview Page Link Complete )

Mismatch repair
  - GTS5:Lynch Syndrome (MLH1, PMS2, MSH2, MSH6)  Incomplete 
  - GTS5:Muir-Torre syndrome (MLH1, PMS2, MSH2, MSH6)  Incomplete 
  - GTS5:Constitutional mismatch repair deficiency (CMMRD) syndrome (MLH1, PMS2, MSH2, MSH6)  Incomplete 
Homologous recombination
  - GTS5:BRCA-related cancer predisposition syndrome (BRCA1, BRCA2)  Complete 
  - GTS5:PALB2-related cancer predisposition syndrome (PALB2)  Complete 
  - GTS5:RAD51-related cancer predisposition syndrome (RAD51C, RAD51D)  Incomplete 
  - GTS5:Fanconi anaemia (FANC genes)  Incomplete 
Base excision repair genes
  - GTS5:MUTYH-associated polyposis (MUTYH)  Incomplete 
  - GTS5:NTHL1-related tumour syndrome (NTHL1)  Incomplete 
  - GTS5:MBD4-associated neoplasia syndrome (MBD4)  Incomplete 
Deficient nucleotide excision repair (NER) of DNA damage
  - GTS5:Xeroderma Pigmentosum  Incomplete 
Non-homologous end joining (NHEJ)
  - GTS5:Ataxia-telangiectasia syndrome (ATM)  Incomplete 
  - GTS5:CHEK2-related hereditary (breast) cancer predisposition syndrome (CHEK2)  Incomplete 
  - GTS5:Nijmegen breakage syndrome (NBN)  Incomplete 
DNA Polymerization
  - GTS5:Polymerase proofreading-associated polyposis (POLD1, POLE)  Incomplete 
Helicases
  - GTS5:Bloom syndrome (BLM)  Incomplete 
  - GTS5:Werner syndrome (WRN)  Incomplete 
  - GTS5:Rothmund-Thomson syndrome (ANAPC1, RECQL4)  Incomplete 
  - GTS5:DDX41-related haematologic tumour predisposition syndrome (DDX41)  Incomplete 
Chromosomal non-dysjunction (aneuploidy) syndromes
  - GTS5:Mosaic variegated aneuploidy (BUB1B, CEP57, TRIP13, BUB1, BUB3)  Incomplete 
  - GTS5:Klinefelter syndrome  Incomplete 
  - GTS5:Turner syndrome  Incomplete 
  - GTS5:Down syndrome  Incomplete 

Telomere maintenance (Overview Page Link Complete )

Telomere biology disorders
  - GTS5:Dyskeratosis congenita (DKC1, TERT, TERC, TINF2, Other IBMFS genes)  Incomplete 
  - GTS5:POT1 and Shelterin-related tumour predisposition syndrome (POT1, ACD, TERF2IP, TERT promoter)  Incomplete 

Epigenetic drivers and chromatin remodelling (Overview Page Link Complete )

Imprinting disorders
  - GTS5:Beckwith-Wiedemann spectrum (IGF2; CDKN1C)  Incomplete 
Histone and DNA methylation
  - GTS5:Enchondromatosis (IDH1, IDH2)  Incomplete 
Chromatin remodelling pathway
  - GTS5:Rhabdoid tumour predisposition syndrome (SMARCB1, SMARCA4)  Incomplete 
  - GTS5:Schwannomatosis (SMARCB1, LZTR1)  Incomplete 
  - GTS5:Clear cell meningioma predisposition syndrome (SMARCE1)  Incomplete 
  - GTS5:Weaver syndrome (EZH2)  Incomplete 

RNA regulation (Overview Page Link Complete )

MicroRNA
  - GTS5:DICER1-related tumour predisposition syndrome (DICER1)  Incomplete 
  - GTS5:MicroRNA processor tumour predisposition syndromes (DROSHA, DGCR8)  Incomplete 
RNA splicing
  - GTS5:Goldenhar syndrome (MYT1, SF3B2)  Incomplete 

Protein regulation (Overview Page Link Complete )

Ubiquitin pathway
  - GTS5:BAP1-related tumour predisposition syndrome (BAP1)  Incomplete